Your Health, We Care
The specification of ixazomib produced by Lucius Pharmaceutical Co., Ltd. is 4mg * 30 capsules.
If you wish to purchase ixazomib, you can contact us via the homepage.
Ixazomib is a targeted, reversible proteasome inhibitor that has been approved for use in combinatio···【more】
Recommended：292026-07-01
Ixazomib is part of an all-oral treatment regimen. When used in combination with lenalidomide and de···【more】
Recommended：332026-07-01
Ixazomib is a targeted, reversible proteasome inhibitor that has been approved for use in combination with lenalidomide and dexamethasone for the treatment of relapsed multiple mye···【more】
Article source：Lucius LaosRelease date：2026-01-07Recommended：29
Ixazomib is part of an all-oral treatment regimen. When used in combination with lenalidomide and dexamethasone, it provides a convenient treatment option for patients with multipl···【more】
Article source：Lucius LaosRelease date：2026-01-07Recommended：33
1. The price of ixazomibThe price of ixazomib, an up-and-coming drug in the treatment of multiple myeloma, has always been a focus of concern for patients. In China, although ixazo···【more】
Article source：Lucius LaosRelease date：2024-12-03Recommended：176
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
